Rivaroxaban Drug Interactions
Currently displaying 233 drugs known to have a moderate interaction with rivaroxaban.
Moderate interactions with rivaroxaban
Note: Showing generic names only.
A
- abametapir topical
- abrocitinib
- adalimumab
- alefacept
- alemtuzumab
- alpelisib
- aminoglutethimide
- amiodarone
- amobarbital
- amprenavir
- anacaulase topical
- anakinra
- aprepitant
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atazanavir
- avacopan
- azithromycin
B
- belzutifan
- bepridil
- berotralstat
- bexarotene
- bimekizumab
- bismuth subsalicylate
- bosentan
- brigatinib
- bromfenac ophthalmic
- butabarbital
- butalbital
C
- calaspargase pegol
- canakinumab
- capmatinib
- cenobamate
- ceritinib
- certolizumab
- chloramphenicol
- choline salicylate
- cimetidine
- citalopram
- clarithromycin
- clomipramine
- clotrimazole
- coagulation factor x
- collagenase clostridium histolyticum
- crizotinib
- cyclosporine
D
- dabrafenib
- daclatasvir
- danicopan
- darolutamide
- darunavir
- delavirdine
- deoxycholic acid
- desvenlafaxine
- dexamethasone
- dexfenfluramine
- diclofenac ophthalmic
- diclofenac topical
- diltiazem
- divalproex sodium
- dong quai
- dronedarone
- duloxetine
- duvelisib
E
- echinacea
- efavirenz
- elacestrant
- elagolix
- eliglustat
- elranatamab
- emapalumab
- enasidenib
- entrectinib
- epcoritamab
- erdafitinib
- erythromycin
- escitalopram
- etanercept
- etravirine
F
- felbamate
- felodipine
- fenfluramine
- fexinidazole
- flibanserin
- fluconazole
- fluoxetine
- flurbiprofen ophthalmic
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fostamatinib
- fostemsavir
- futibatinib
G
- garlic
- gilteritinib
- ginger
- ginkgo
- ginseng
- givinostat
- glasdegib
- glofitamab
- golimumab
- griseofulvin
- guselkumab
H
I
K
L
- lapatinib
- larotrectinib
- lasmiditan
- lefamulin
- lenacapavir
- leniolisib
- letermovir
- levetiracetam
- levomilnacipran
- lomitapide
- lonapegsomatropin
- lorlatinib
M
- magnesium salicylate
- maribavir
- mavacamten
- mavorixafor
- mephobarbital
- miconazole
- midostaurin
- milnacipran
- mitapivat
- mobocertinib
- momelotinib
- mosunetuzumab
N
- nafcillin
- nefazodone
- nepafenac ophthalmic
- neratinib
- nevirapine
- nifedipine
- nilotinib
- nintedanib
- niraparib
O
P
- pacritinib
- paroxetine
- pegaspargase
- pemigatinib
- pentobarbital
- pentosan polysulfate sodium
- pentoxifylline
- pexidartinib
- pirtobrutinib
- pralsetinib
- protein c
Q
R
- ranolazine
- repotrectinib
- resmetirom
- ribociclib
- rifabutin
- rilonacept
- ripretinib
- ritlecitinib
- rolapitant
- ropeginterferon alfa-2b
- rucaparib
S
- sarecycline
- sarilumab
- satralizumab
- secobarbital
- secukinumab
- selpercatinib
- selumetinib
- sertraline
- sibutramine
- siltuximab
- sodium iodide i-123
- sodium iodide-i-131
- sodium salicylate
- sodium thiosalicylate
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sorafenib
- sotorasib
- stiripentol
- sugammadex
- sunitinib
- suprofen ophthalmic
- suvorexant
T
- tacrolimus
- tafasitamab
- talquetamab
- tarlatamab
- tebentafusp
- teclistamab
- tedizolid
- telotristat
- tepotinib
- tivozanib
- tocilizumab
- tolvaptan
- trofinetide
- troglitazone
- troleandomycin
- turmeric
U
V
- valproic acid
- vemurafenib
- venetoclax
- venlafaxine
- verapamil
- verteporfin
- vilazodone
- vitamin e
- vortioxetine
- voxelotor
Rivaroxaban disease interactions
There are 6 disease interactions with rivaroxaban which include:
- bleeding
- valvular heart disease
- antiphospholipid syndrome
- hepatic impairment
- renal disease
- unstable blood pressure
More about rivaroxaban
- rivaroxaban consumer information
- Check interactions
- Compare alternatives
- Reviews (245)
- Side effects
- Dosage information
- During pregnancy
- Drug class: factor Xa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.